were inhibited by IPC in WT mice, but not by IPC in PKO mice. Conclusions: IPC inhibits mPTP opening by regulating the PTEN/PDE4 signaling pathway.
Introduction
Reperfusion following prolonged ischemia causes substantial myocardial injury, contributing to mortality and morbidity of myocardial infarction [1, 2] . Ischemic preconditioning (IPC), consisting of one or several brief periods of ischemia and reperfusion, generates powerful protection against ischemia-reperfusion (IR) injury [3] . However, the molecular mechanism underlying IPC is still poorly understood [4] . Reperfusion saves the ischemic myocardium, but it results in calcium overload, which is an important factor in promoting mitochondrial permeability transition pore (mPTP) opening and subsequent cell death [2, 5, 6] . It has been reported that IPC inhibits mPTP opening through activation of Akt [7] .
Akt activity is regulated by phosphatidylinositol (PI) 3-kinase (PI3K) and PTEN (phosphatase and tensin homologue deleted on chromosome ten). PI3K activates Akt by phosphorylating PI bisphosphate to PI 3,4,5-triphosphate (PIP3) at the plasma membrane, whereas PTEN reverses this process, leading to Akt inactivation [8] . Akt can be localized to caveolae (lipid-rich microdomains of the plasma membrane) [9] . Caveolae are essential for IPC induction [10] [11] [12] . However, many studies have suggested that Akt mediates cardioprotection against IR injury by regulating translocation of Bcl-2 family proteins and glycogen synthase kinase (GSK)-3β from the cytosol to the mitochondria [9, [13] [14] [15] [16] . Where Akt exerts its protection against IR injury has not been defined.
Caveolae contain many signaling molecules involved in the regulation of calcium influx, including L-type calcium channels, β-adrenoceptors and cAMP-dependent protein kinase (PKA) [17] . The formation of caveolae is promoted by its structural protein caveolin (Cav) [18] . There are three Cav isoforms, and Cav-3 is myocyte specific [19] . Cav-3 acts as a scaffolding domain to assemble signaling complexes [20] . L-type calcium channels are activated by PKA, but local cAMP levels are mainly dependent on PDE4 (phosphodiesterase 4) activity [21] . Decreased PDE4 activity has been implicated in the pathogenesis of heart failure and arrhythmias [22] . PDE4D is the major isoform of PDE4 existing in rodent hearts. PDE4D can be recruited to the plasma membrane through β-arrestin [23] . In the present study, we tested the hypothesis that IPC promotes PDE4D localization to the plasma membrane through PTEN inactivation, preventing calcium entry and mPTP opening after IR.
Methods

Animals
All experiments were performed with age-matched male mice. At the time of the experiments, mice were 8-10 weeks old. Myocyte-specific PTEN knockout (PKO) mice ( Pten loxp/loxp ;ckmCre +/-) were generated by loxp-cre technology. Their phenotypes were described previously [24] . Briefly, PKO mice are characterized by physiological cardiac hypertrophy. All procedures were approved by our Institutional Animal Care and Use Committee and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Mouse Langendorff Preparation
The Langendorff preparation was performed as described previously [25] . Briefly, after mice were anesthetized with pentobarbital (70 mg/kg), hearts were isolated. The ascending aorta was cannulated with a blunt needle. The heart was perfused at a constant pressure of 100 cm H 2 O with modified Krebs-Henseleit buffer (in m M : glucose 17, NaCl 120, NaHCO 3 25, CaCl 2 2.5, KCl 5.9, MgSO 4 1.2 and EDTA 0.5), which was maintained at 37 ° C and bubbled continuously with a mixture of 95% O 2 and 5% CO 2 . Global ischemia was induced by cessation of perfusion, followed by reperfusion. Isolated hearts from wild-type (WT) mice and PKO mice were exposed to IPC, consisting of 10-min ischemia and 5-min reperfusion (I-10/R-5) or an equivalent period of normal perfusion followed by 30-min ischemia and 120-min reperfusion (I-30/R-120).
Assessment of Myocardial Infarct Size
Infarct size (IS) was determined as described previously [25] . At the end of experiments, mouse hearts were perfused with triphenyltetrazolium chloride for 1 min and then incubated with 1% triphenyltetrazolium chloride at 37 ° C for 15 min. After freezing at -80 ° C, hearts were transected into 5 pieces, each of which was weighed. Cardiac sections were incubated with 10% formalin for 30 min. Both sides (A and B) of each section were photographed. Viable myocardium stains red and infarcted tissue was white. The areas of red and white color in the left ventricle (LV) and the muscle area of cardiac sections were measured by computerized planimetry (ImageJ; NIH, Bethesda, Md., USA). Total LV infarct weight was determined by the equation:
where S is the area of LV infarction for the slice represented by the subscript, C is the muscle area of the cardiac section, and W is the weight of that respective section. Total weight of viable myocardium in LV was calculated in a similar fashion. IS was calculated as a percentage of LV as follows: IS/LV = total infarct weight/(total infarct weight + total weight of viable myocardium) × 100%.
Subcellular Fractionation
Enrichment of caveola membranes with detergent-free reagents was performed as described previously [26] . Briefly, hearts were homogenized in 0.5 M sodium carbonate (pH 11). The homogenate was suspended in an equal volume of 80% sucrose prepared in MES-buffered saline. The solution was placed at the bottom of an ultracentrifuge tube, overlaid with 5-35% discontinuous sucrose gradient followed by 16 h of centrifugation at 38,000 rpm. After centrifugation, 12 gradient fractions (1 ml) were concentrated by precipitation with trichloroacetic acid. The pellets of the 12 fractions (from top to bottom) were washed and dissolved in sample buffer and loaded onto 12 lanes (from left to right, respectively) of one SDS-PAGE gel.
Measurement of PDE4 Activity PDE4 activity was measured by a PDE-Glo TM PDE assay kit (Promega Corp., Madison, Wisc., USA). PDE4 negatively regulates cAMP levels. cAMP binds the inactive PKA holoenzyme. Released catalytic subunits of PKA consume ATP. The level of remaining ATP was measured by luminescence assay using the luciferase-based Kinase-Glo reagent. PDE4 activity is directly proportional to the remaining ATP levels. According to the manufacturer's instructions, 10 μg of Cav-3-enriched membrane protein were incubated with cAMP (1 μ M ) to initiate the PDE reaction. The PDE-Glo TM termination buffer containing the PDE4 inhibitor (rolipram, Ro, 100 μ M ) and detection solution were added and mixed well. The Kinase-Glo reagent was added and incubated for 10 min at room temperature. Luminescence was measured using a platereading luminometer.
Assessment of Intracellular Ca 2+ Levels
Intracellular free Ca 2+ [Ca 2+ ] levels were measured with a Rhod-2 AM fluorescent probe (Anaspec Inc., Fremont, Calif., USA) as previously described, with modifications [27] . Rhod-2 AM is membrane permeable and becomes a Ca 2+ -sensitive fluorescence probe when trapped in the cytosol and deesterified to Rhod-2. Rhod-2 dye (25 μg/ml in 2 ml) was added without recirculation through a parallel infusion line just above the aortic cannula. During loading, only the bolus line was opened. Dye loading was followed by a 10-min washout period with the perfusion buffer to remove extracellular dye. Ro was added into the perfusion line during the washout. At the end of the experiment, heart tissues were homogenized in Ca i 2+ -free Krebs-Henseleit buffer. Equal amounts (100 μg) of protein from each sample were loaded into each well. Plates were read at 531 nm (excitation) and 593 nm (emission).
Measurement of mPTP Opening in Isolated Hearts
mPTP opening in mouse hearts was assessed as previously described, with modifications [28] . Briefly, isolated hearts were balanced with the perfusion buffer and loaded with 1 μ M calcein-AM (Anaspec Inc.) for 15 min. During the last 5 min of calcein-AM perfusion, CoCl 2 (200 μ M ) was added into the perfusion line to quench the cytosolic calcein signal. Remaining calcein in the extracellular space was washed out with a 10-min perfusion in the absence or presence of inhibitors, followed by I-30/R-15. At the end of the experiment, heart tissues were homogenized on ice in calcium-free buffer, followed by centrifugation at 12,000 rpm for 10 min. Supernatants (cytosolic fractions) were collected for protein concentration measurements. Calcein fluorescence was measured at 484-nm excitation and 520-nm emission in 100 μg of protein. Without IR, low fluorescence intensity was detected in the cytosolic fractions while high fluorescence intensity was found in the mitochondrial fractions (from pellets after centrifugation), suggesting that mPTP were closed. Inhibitors were added into the perfusion line 5 min before I-30.
Immunoprecipitation and Immunoblotting Assay
Cardiac tissues were homogenized in lysis buffer (in m M : Tris 20, NaCl 150, EDTA 1, EGTA 1, PMSF 1, Na 3 VO 4 1; 1% Triton; pH 7.5). Heart lysates were incubated with primary antibody overnight at 4 ° C. The target protein was pulled down following 2-hour incubation with G-protein agarose beads. Proteins were detected using primary antibodies, followed by horseradish peroxidaseconjugated secondary antibody and enhanced chemiluminescence. Antibodies against PTEN, β-arrestin, p-Akt (S-473) and total Akt were purchased from Cell Signaling Technology (Danvers, Mass., USA). PDE4D antibody was from Santa Cruz Biotechnology (Santa Cruz, Calif., USA).
Statistical Analysis
Data are presented as means ± SEM. Differences among groups were analyzed using ANOVA with the Tukey post hoc test and considered significant if p < 0.05.
Results
PTEN and PDE4 Are Required for IPC-Induced Cardioprotection against IR Injury
We previously reported that PTEN inactivation confers cardioprotection against IR injury in isolated mouse hearts [25] . In the present study, IPC decreased IS in WT (IPC/WT) mice. Small IS was seen in control (CON)/PKO mice. Surprisingly, IPC increased IS in PKO mice to levels similar to those seen in WT/CON mice ( fig. 1 ), suggesting that IPC abolishes the native protection in PKO mice. Since PDE4 plays an important role in regulating local cAMP levels and L-type calcium channel activity, we wondered whether PDE4 is involved in cardioprotection induced by IPC and PTEN inactivation. Hearts from IPC/WT and CON/PKO were treated with Ro, a PDE4 inhibitor, followed by I-30/R-120. Ro inhibited the infarct-limiting effect in these two groups ( fig. 1 ). These results suggest that PTEN and PDE4 are necessary for IPC cardioprotection against IR injury.
IPC Promotes Localization of Akt and PDE4D to the Plasma Membrane by Regulating PTEN/Akt
Many studies have reported that the PI3K/Akt signaling pathway plays an important role in IPC cardioprotection [6, 8] . This signaling pathway cross talks with PTEN at the plasma membrane [8, 9] . To determine whether PTEN inactivation affects Akt localization to the plasma membrane, subcellular fractionations were performed after exposure of isolated hearts to CON or IPC. The same volumes of samples from 12 fractions were loaded onto SDS-PAGE gels for protein analysis. Cav-3-enriched fractions were identified in lane 4 ( fig. 2 a) . Only small amounts of Akt were localized at the subcellular domain ( fig. 2 b) . To compare Akt protein levels, the same amounts of proteins from the Cav-3-enriched fractions were loaded onto SDS-PAGE gels. IPC increased Akt protein levels in WT mice ( fig. 2 c) . The PI3K inhibitor LY20094 (LY) blocked this effect ( fig. 2 c) . However, in PKO mice, there were high basal levels of Akt protein at the Cav-3-enriched fractions, and IPC decreased Akt protein levels when compared with CON ( fig. 2 c) , suggesting that PTEN is required for Akt localization to the caveolae at the plasma membrane in IPC.
To determine whether Akt regulates PDE4D localization, PDE4D protein levels in 12 subcellular fractions and Cav-3-enriched fractions were measured. Under basal conditions, few amounts of PDE4D were detected in Cav-3-enriched fractions, and PDE4D protein levels at the microdomain were regulated by the treatments ( fig. 3 a) . IPC increased PDE4D protein levels compared with CON in WT mice, and this effect was inhibited by LY ( fig. 3 b) . This suggests that PDE4D localization to the caveolae requires Akt activation. Consistent with Akt protein levels, PDE4D protein levels were elevated under basal conditions in PKO mice ( fig. 3 b) . IPC decreased PDE4D protein levels when compared with CON/PKO ( fig. 3 b) . In a similar way, IPC increased PDE4 activity in Cav-3-enriched fractions in WT mice, and LY inhibited this effect. In PKO mice, PDE4 activity at the microdomain was increased under basal conditions; IPC decreased its activity ( fig. 3 c) . Taken together, these results suggest that activated Akt modulates PDE4D protein levels at the caveolea.
IPC Promotes the Association between Akt, β-Arrestin, and PDE4D at the Plasma Membrane
To determine whether the adaptor β-arrestin interacts with PDE4D and Akt, associations between β-arrestin, PDE4D and Akt were determined. Akt or PDE4D was pulled down from Cav-3-enriched fractions generated from WT/IPC hearts. The membrane was immunoblotted with β-arrestin antibody. β-Arrestin was found in the immunoprecipitates ( fig. 4 ) . In a reverse experiment, β-arrestin was pulled down from the same lysates and followed by immunoblotting of Akt or PDE4D. Akt and PDE4D were present in the immunoprecipitates ( fig. 4 ) . These results suggest that Akt is associated with β-arrestin and PDE4D at the plasma membrane.
IPC Inhibits Ca 2+ Overload in the Ischemic Heart through PDE4
To determine whether PDE4D localization to the plasma membrane inhibits intracellular Ca 2+ overload in the ischemic heart, we exposed isolated hearts from WT mice to nonischemia (NIS), I-30 (CON), I-10/R-5 plus I-30 in the absence or presence of Ro (IPC or IPC/Ro; fig. 5 a) . IPC decreased intracellular Ca 2+ levels at the end of ischemia compared with CON/WT, and Ro abolished the inhibitory effect of IPC in the ischemic heart ( fig. 5 b) . However, in PKO mice, there was no significant difference between NIS and CON ( fig. 5 b) . Without PTEN, IPC increased intracellular Ca 2+ levels in the ischemic heart compared with CON; moreover, Ro had a similar effect ( fig. 5 b) .
IPC Inhibits mPTP Opening in the Heart through PDE4
Increased intracellular Ca 2+ levels are directly associated with mPTP opening, leading to cell death. To determine whether IPC inhibits mPTP opening after IR, we exposed isolated hearts from WT mice to NIS, I-30/R-15 (CON), CON plus cyclosporine A (CsA), CON plus verapamil (Ve), I-10/R-5 plus CON (IPC) and IPC/Ro ( fig. 6 a) . CON caused a significant increase in fluorescence intensity compared with NIS, indicating mPTP opening ( fig. 6 b) . CsA or Ve inhibited the increase ( fig. 6 b) , suggesting that the assay of mPTP opening was accurate. Consistent with the intracellular Ca 2+ levels in the ischemic heart, IPC inhibited mPTP opening in WT mice, and this effect was abolished by Ro ( fig. 6 b) . Moreover, hearts from PKO mice were exposed to NIS, CON, IPC, IPC/Ve and CON/Ro. CON did not cause mPTP opening in PKO mice; however, the protection was lost after IPC ( fig. 6 c) . Ve reversed the detrimental effect of IPC, and Ro resulted in mPTP opening in CON ( fig. 6 c) . These results suggest that mPTP opening is dependent on PDE4 and L-type calcium channel activities in the heart exposed to IR. IPC promotes associations between Akt, β-arrestin (Arr) and PDE4D in Cav-3-enriched fractions. Cav-3 enriched fractions (M) from IPC/WT hearts were immunoprecipitated with an antibody against Akt or PDE4D, followed by immunoblotting with antibodies against β-Arr ( a ). In a reverse experiment, cell lysates were pulled down with β-Arr antibody, followed by immunoblotting with antibodies against Akt or PDE4D ( b ). Representative blots from at least 3 independent experiments. W = Whole cell lysates. 
Discussion
In the present study, we report three important findings. First, we demonstrate that PTEN is required for IPC induction. In PKO mice, IPC did not reduce myocardial IS after IR. Second, we show that IPC promotes localization of PDE4D to the caveolae in the heart by regulating the PTEN/Akt pathway. Akt inhibition blocked PDE4D localization to the plasma membrane induced by IPC and PTEN inactivation. Third, we demonstrate that PDE4 plays an important role in controlling calcium overload and mPTP opening. PDE4 inhibition abolished the inhibition of calcium overload and mPTP opening in IPC/ WT mice. Therefore, the present study has demonstrated that PTEN plays a critical role in response to ischemia and activation of the Akt/PDE4 signaling pathway at the plasma membrane. This may lead to inhibition of calcium overload and mPTP opening after IR. Many studies have reported that IPC activates the PI3K/Akt signaling pathway and protects the heart from IR injury [13, 16] . However, the role of PTEN in IPC is not fully understood. In the present study, we showed that IPC inhibits Akt phosphorylation in PTEN-deficient hearts. It suggests that Akt requires PI3K and PTEN for its activation. IPC increases Akt phosphorylation in the myocardium of WT rats [13] . However, brief ischemia without reperfusion has been shown to cause a modest increase in Akt phosphorylation [29] . Ischemia decreases PTEN protein levels in the heart. PTEN inactivation itself can be sufficient to increase Akt phosphorylation if PI3K activity remains unchanged. As a protein enzyme, PI3K is likely impaired by ischemia. Early reperfusion further suppresses PTEN activity through reactive oxygen species [29] . Although PI3K is essential for PIP3 production, which causes Akt activation, the present study suggests PI3K itself is insufficient to activate Akt in the preconditioned heart. Therefore, despite the importance of PI3K, PTEN inactivation is the key factor in Akt activation and IPC induction. PI3K and PTEN may also be associated with activation of other reperfusion injury salvage kinases such as p42/p44 [29] [30] [31] . However, their role in IPC is less certain [32, 33] .
PDE4D plays an important role in regulating the spatiotemporal dynamics of cAMP signals in rodent cardiomyocytes [20] . At the plasma membrane, L-type Ca 2+ channel activity is associated with compartmentalized cAMP signaling through PKA [20, 21] . L-type Ca 2+ channels, PKA, β-arrestin and Akt have been identified in the caveolae of cardiac myocytes [21, 34] . β-Arrestin may be the key for recruiting PDE4D to the plasma membrane. It has been reported that β-arrestin is involved in the modulation of β 2 -adrenoceptor signaling and induction of IPC [23, [35] [36] [37] . In the present study, we demonstrate that β-arrestin is associated with PDE4D and Akt in preconditioned membrane fractions. Akt has been shown to form a complex with PDE4D through β-arrestin at the plasma membrane, promoting localization of PDE4D [38] . Consistent with the finding, the present study showed that IPC-induced Akt activation increases localization of PDE4D to caveolae, suggesting that PDE4D may mediate the compartmentalization of cAMP at the plasma membrane and limit later increase in L-type Ca 2+ channel activity by reducing local PKA activity in the preconditioned heart. IPC has been shown to inhibit necrosis and apoptosis in the infarcted heart through the PI3K/PTEN/Akt signaling pathway [13, 14, 39] . However, necrotic cell death is critically related to calcium overload and subsequent mPTP opening while apoptotic cell death is promoted by release of cytochrome c [40] . Akt regulates Bcl-2 family proteins and blocks the release of cyto- Fig. 7 . A hypothesis of IPC-induced cardioprotection. IPC inactivates PTEN and decreases dephosphorylation of PIP3, which is produced by PI3K. PIP3 elevation causes Akt activation. Activated Akt promotes the localization of PDE4D to the caveolae at the plasma membrane through β-arrestin (Arr) and thereby induces the compartmentalization of cAMP signaling, limiting later increase in PKA activity and L-type calcium channel (LC) opening in response to lethal IR. This prevents activation of caspases and cell death from calcium overload and mPTP opening in reperfused hearts. PM = Plasma membrane; Mt = mitochondria. chrome c from mitochondria [40, 41] . In the present study, our results suggest that Akt may inhibit calcium overload in the ischemic heart by increasing PDE4D localization to the plasma membrane. This provides new insights into the molecular mechanism by which IPC inhibits both necrosis and apoptosis. Our observations are consistent with previous reports in which Cav-3 deficiency or a defect in the plasma membrane resulted in loss of IPC [11, 42] . GSK-3β has been implicated in the inhibition of mPTP opening, and GSK-3β is a substrate of Akt [43] . Further studies are needed to determine whether Akt regulates GSK-3β at the plasma membrane.
Based on the present study and previous observations, a hypothesis of IPC-induced cardioprotection is proposed ( fig. 7 ).
In conclusion, IPC inactivates PTEN and promotes PDE4D localization to the plasma membrane through Akt, leading to inhibition of calcium overload in ischemic hearts and mPTP opening after IR.
